Dr. Philip Butler

Dr. Philip Butler
Dr. Butler is certified by the American Board of Urology and has been honored as a Fellow of the American College of Surgeons (FACS). A Founding member of Genesis Healthcare Providers, he has been practicing with The Coast Urology Division since 1986. He attended the University Of Oregon, and then graduated with honors at the University of California, Irvine. He earned his Medical Doctorate from New York Medical College before returning to California to complete his 6 year residency training in Surgery and Urology at The University of California, San Diego Medical Center. His medical peers have selected him multiple times as a TOP DOCTOR in San Diego. Dr. Butler is presently chairman of the Section of Urology at Scripps Memorial Hospital, La Jolla and has offices on the campus of both Scripps Memorial hospitals, in La Jolla and Encinitas. Dr. Butler has specialized in less invasive surgical techniques for Kidney stones and prostate disease: Including the use of LASER therapy and hyperthermia (Greenlight laser, Prostiva and Microwave). He is pioneering the use of Prostatic Implants (Urolift) , a revolutionary new treatment for BPH – Benign Prostate Hyperplasia. He is commonly able to perform these in the office setting under local anesthesia. Dr. Butler has extensive experience in prostate cancer, Botox and Nerve Stimulation Incontinence therapy, Laparoscopy and sexual dysfunction. He is active in clinical research through our Genesis Research Division.
Medical School:

New York Medical College

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only